首页> 外国专利> NUTRITIONAL SUPPORT TO PREVENT OR MODERATE BONE MARROW PARALYSIS OR NEUTROPENIA DURING ANTI-CANCER TREATMENT.

NUTRITIONAL SUPPORT TO PREVENT OR MODERATE BONE MARROW PARALYSIS OR NEUTROPENIA DURING ANTI-CANCER TREATMENT.

机译:在预防癌症的过程中提供营养支持,以预防或减轻骨骼骨髓麻痹或中性神经减少症。

摘要

The present invention relates to methods and immunonutritional compositions for preventing the impairment of the immune function during anti-cancer therapy, thereby attaining a better efficacy of the treatment. More particularly, the present invention relates to methods and immunonutritional compositions that can transiently preventing or moderating, bone marrow paralysis or neutropenia of a subject undergoing anti-cancer therapy-induced apoptosis or necrosis or other cell damage such that the innate and adaptive immune functions and normal physiology of the bone marrow are preserved, at least in part, which, in turn, lead to (i) a better tolerance and increased efficacy to anti-cancer therapy; (ii) transient augmentation or enhancement of immunocompetence of the immune cell; and (iii) optimization of the effects of and increase of immunocompetence of the immune cell weakened by anti-cancer therapy.
机译:本发明涉及用于在抗癌治疗期间防止免疫功能受损从而获得更好的治疗功效的方法和免疫营养组合物。更具体地,本发明涉及可以暂时预防或调节经历抗癌疗法诱导的细胞凋亡或坏死或其他细胞损伤的受试者的骨髓麻痹或中性粒细胞减少症的方法和免疫营养组合物,从而固有和适应性免疫功能和至少部分保留了骨髓的正常生理,这反过来又导致(i)更好的耐受性和对抗癌治疗的疗效提高; (ii)瞬时增强或增强免疫细胞的免疫能力; (iii)优化被抗癌疗法削弱的免疫细胞的作用并提高免疫能力。

著录项

  • 公开/公告号MX2011002983A

    专利类型

  • 公开/公告日2011-04-11

    原文格式PDF

  • 申请/专利权人 NESTEC S.A.;

    申请/专利号MX20110002983

  • 申请日2009-09-11

  • 分类号A23L33;A61K31/195;A61K31/20;A61K31/7088;A61K35/20;A61K35/74;A61K35/745;A61K35/747;A61K38;A61K38/40;A61P35;A61P37/04;

  • 国家 MX

  • 入库时间 2022-08-21 18:05:23

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号